Single-cell-pore-sized 3D printed scaffolds for retinal pigment epithelial cell therapy
Acta Biomaterialia · 2025
DOI: 10.1016/j.actbio.2025.10.033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2025. Verfasst von Hang Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore; Inst…. Hauptthemen laut MEDLINE: Printing, Three-Dimensional, Tissue Scaffolds, Retinal Pigment Epithelium, Human Embryonic Stem Cells. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Education - Singapore, National Medical Research Council, National University of Singapore.
Abstract (Originalsprache)
Cell therapy is one of the most promising methods to treat retinal degenerative diseases, and crucial to its success is optimizing biomaterials to facilitate the delivery of retinal pigment epithelial (RPE) cells. This study explores the application of single-cell-pore-sized 3D printed polycaprolactone (PCL) scaffolds for cultivating human embryonic stem cell-derived RPE cell sheets. It compares them with track-etched polyethylene terephthalate (PET) membranes, the commercial products used in clinical trials for RPE cell delivery. We engineered two types of scaffolds at the microscale to optimize cell culture conditions, specifically focusing on pore size and fiber spacing. Protein expression analysis demonstrated that one scaffold with a pore size of ∼10 µm facilitated superior cellular integrity and function. Functional assessments, including barrier integrity, permeability, and phagocytosis assays, indicated that this scaffold enhanced nutrient exchange and maintained effective RPE functions akin to PET membranes. In an in vivo study, color fundus, optical coherence tomography, immunohistochemistry, and electroretinography revealed that 3D printed scaffolds exhibited biocompatibility, stability, and minimal inflammatory responses in the subretinal space of porcine models for 2 months and rabbit models for 14 months, with no adverse impact on retinal structure or function over either period. The findings suggest that 3D-printed biodegradable scaffolds present a viable alternative for RPE cell delivery, potentially advancing therapies for retinal degenerative conditions. STATEMENT OF SIGNIFICANCE: Cell therapy shows great promise for treating eye diseases that lead to vision loss. A crucial aspect of this therapy is delivering specialized retinal pigment epithelial (RPE) cells effectively. Our research presents a 3D-printed scaffold made from polycaprolactone (PCL), designed to carry RPE cells derived from human stem cells and dissolve after placement in the eye. We tested this scaffold in rabbits and pigs to evaluate its surgical handling, cell delivery effectiveness, and safety for human application. Our results refine implant design, paving the way for safer and more effective treatments for retinal diseases. Overall, this research enhances the application of cell therapy with scaffolds and offers valuable insights for future medical practices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Techno…
- Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore.
- Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Singapore 138673, Singapore; Department of Endocrinology, The First Affiliated Hospital of Harbin…
- Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Singapore 138673, Singapore.
- Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Singapore 138634, Singapore.
- Department of Food Science and Technology, Faculty of Science, National University of Singapore, 2 Science Drive 2, Singapore 117543, Singapore.
Förderung
- Ministry of Education - Singapore
- National Medical Research Council
- National University of Singapore
- Singapore Eye Research Institute
- National Research Foundation
Zitieren
APA
Liu, H., Wong, D. S. L., Parikh, B. H., Hao, M., Tan, Q. S. W., Chee, P. L., Lou, X., Kai, D., Lingam, G., Huang, D., Su, X., & Liu, Z. (2025). Single-cell-pore-sized 3D printed scaffolds for retinal pigment epithelial cell therapy. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2025.10.033
Vancouver
Liu H, Wong DSL, Parikh BH, Hao M, Tan QSW, Chee PL, et al. Single-cell-pore-sized 3D printed scaffolds for retinal pigment epithelial cell therapy. Acta Biomaterialia. 2025. doi:10.1016/j.actbio.2025.10.033
BibTeX
@article{Liu2025,
author = {Liu, Hang and Wong, Daniel Soo Lin and Parikh, Bhav Harshad and Hao, Ming and Tan, Queenie Shu Woon and Chee, Pei Lin and Lou, Xiaowei and Kai, Dan and Lingam, Gopal and Huang, Dejian and Su, Xinyi and Liu, Zengping},
title = {Single-cell-pore-sized 3D printed scaffolds for retinal pigment epithelial cell therapy},
journal = {Acta Biomaterialia},
year = {2025},
doi = {10.1016/j.actbio.2025.10.033}
}
EUVIMED